Login / Signup
Yusuf Karabulut
ORCID
Publication Activity (10 Years)
Years Active: 2021-2022
Publications (10 Years): 5
Top Topics
Patient Reported Outcomes
Rheumatoid Arthritis
Interstitial Lung Disease
Cross Sectional
Top Venues
Rheumatology international
European journal of rheumatology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yusuf Karabulut
,
Halise Hande Gezer
,
Selin Aktürk Esen
,
İrfan Esen
,
Ali Riza Turkoglu
Tofacitinib monotherapy and erectile dysfunction in rheumatoid arthritis: a pilot observational study.
Rheumatology international
42 (9) (2022)
Yusuf Karabulut
,
Halise Hande Gezer
,
Nuran Oz
,
İrfan Esen
,
Mehmet Tuncay Duruöz
Real-life data on tapering or discontinuation of canakinumab therapy in patients with familial Mediterranean fever.
Rheumatology international
42 (12) (2022)
Yusuf Karabulut
,
Nuran Oz
,
Halise Hande Gezer
,
İrfan Esen
,
Mehmet Tuncay Duruöz
Perspective of sarcoidosis in terms of rheumatology: a single-center rheumatology clinic experience.
Rheumatology international
42 (12) (2022)
Yusuf Karabulut
,
Halise Hande Gezer
,
Mehmet Tuncay Duruöz
Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
Rheumatology international
(2021)
Yusuf Karabulut
Use of non-TNF biologics for the treatment of neuro-Behçet's disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab.
European journal of rheumatology
(2021)